...
首页> 外文期刊>Medicinal chemistry >Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity
【24h】

Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity

机译:(2-(吡啶基)亚甲基)-1-Tetralone Chalcones用于抗癌和抗微生物活性的设计,合成和评价

获取原文
获取原文并翻译 | 示例

摘要

Background: Chalcones, natural products produced by plants as a natural defensemechanisms against various pathogens, are molecules with structures that include two aromaticrings joined by an α, β unsaturated carbonyl system. Previous research has demonstrated that chalconesexhibit a wide variety of biological activities, including anticancer, antifungal, and antibioticproperties.Objective: Our goal is to synthesize novel heterocyclic-containing chalcones and have their biologicalactivities evaluated.Methods Sixteen chalcones were synthesized by the crossed aldol condensation of substitutedtetralones with substituted pyridinylaldehydes. The products were purified by recrystallization inMeOH/H2O and characterized by 1H NMR, 13C NMR, and HRMS. Anticancer assays were performedby NCI (National Cancer Institute) against the NCI-60 panel of 60 different human cancercell lines, including leukemia, non-small-cell lung cancer, colon, central nervous system, melanoma,ovarian, renal, prostate, and breast cancer. Antimicrobial assays were performed by COADD(Community for Open Antimicrobial Drug Discovery) against Escherichia coli, Klebsiellapneumonia, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Cryptococcusneoformans var. grubii, and Candida albicans.Result: Chalcone 3d had demonstrated growth inhibition greater than 60% against a variety ofcancers: leukemia (MOLT-4, SR), non-small cell lung cancer (NCI-H522), colon cancer (HCT-116), prostate cancer (DU-145), and breast cancer (MCF7, MDA-MB-468) and was also cytotoxicto three different cell lines (CCRF-CEM, RPMI-8226, and KM12). 5c was active against leukemia(CCRF-CEM, RPMI-8226, SR) and breast cancer (MCF7) and 5e was active only against leukemia(RPMI-8226, SR). 5h was partially active and the best compound with growth inhibition ofMRSA by 75%. 3b was the best compound against EC, KP, and PA and 3f had the greatest activityagainst AB. For fungi, 3f and 3e demonstrated the best growth inhibition.Conclusion: A small library of heterocyclic-containing chalcones was developed and initialscreening demonstrates modest activity against cancers, bacteria, and fungi.
机译:背景:Chalcones,由植物产生的天然产品作为针对各种病原体的自然防御机制,是具有结构的分子,其包括由α,β不饱和羰基体系连接的两个芳香族。以前的研究表明,Chalconesex乏力各种各样的生物活性,包括抗癌,抗真菌和抗生素。目的:我们的目标是合成新的含杂环的硫氨酸,并通过交叉的醛醇缩合合成了其生物活性。用取代的吡啶基醛取代替代rolyones。通过在MeOH / H 2 O中重结晶纯化产物,其特征在于1H NMR,13C NMR和HRMS。 NCI(国家癌症研究所)对抗癌的抗癌测定对60种不同人类癌症系列,包括白血病,非小细胞肺癌,结肠癌,中枢神经系统,黑素瘤,卵巢癌,肾,前列腺和乳房癌症。通过Coadd(群落进行开放的抗菌药物发现)进行抗菌药物,对抗大肠杆菌,Klebsiellapneumonia,肺炎枢纽,假单胞菌铜绿素,金黄色葡萄球菌,Cryptococusneoformans var。 Grubii和Candida albicans.Result:Chalcone 3D对各种癌症的增长抑制超过60%:白血病(Molt-4,SR),非小细胞肺癌(NCI-H522),结肠癌(HCT-116 ),前列腺癌(DU-145)和乳腺癌(MCF7,MDA-MB-468),也是三种不同细胞系(CCRF-CEM,RPMI-8226和KM12)的细胞毒素。 5C针对白血病(CCRF-CEM,RPMI-8226,SR)和乳腺癌(MCF7)和5E仅针对白血病(RPMI-8226,SR)有效。 5h是部分活性的,最佳化合物,其生长抑制为75%。 3B是针对EC,KP和PA和3F的最佳化合物,具有最大的敏捷AB。对于真菌,3F和3E证明了最佳的生长抑制性。结论:开发了一种小含杂环的含杂环内的文库,初始筛选对抗癌症,细菌和真菌的适度活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号